UnitedHealth Group Incorporated (UNH) Shares Bought by Jacobi Capital Management LLC

Jacobi Capital Management LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 729 shares of the healthcare conglomerate’s stock after purchasing an additional 45 shares during the period. Jacobi Capital Management LLC’s holdings in UnitedHealth Group were worth $136,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. State Street Corp lifted its position in shares of UnitedHealth Group by 2.5% during the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after acquiring an additional 1,122,534 shares in the last quarter. Alliancebernstein L.P. lifted its position in shares of UnitedHealth Group by 2.3% during the second quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after acquiring an additional 174,290 shares in the last quarter. Veritas Asset Management LLP lifted its position in shares of UnitedHealth Group by 8.2% during the second quarter. Veritas Asset Management LLP now owns 5,291,867 shares of the healthcare conglomerate’s stock worth $981,218,000 after acquiring an additional 399,878 shares in the last quarter. Legal & General Group Plc lifted its position in shares of UnitedHealth Group by 2.6% during the second quarter. Legal & General Group Plc now owns 5,085,698 shares of the healthcare conglomerate’s stock worth $943,004,000 after acquiring an additional 131,006 shares in the last quarter. Finally, American Century Companies Inc. lifted its position in shares of UnitedHealth Group by 16.9% during the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after acquiring an additional 681,111 shares in the last quarter. Institutional investors and hedge funds own 86.00% of the company’s stock.

In other news, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the sale, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the sale, the insider now owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 72,149 shares of company stock valued at $14,212,342. 0.89% of the stock is currently owned by company insiders.

UnitedHealth Group Incorporated (NYSE UNH) opened at $211.71 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $148.56 and a 12 month high of $213.93. The stock has a market capitalization of $204,541.08, a PE ratio of 21.99, a PEG ratio of 1.57 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same period last year, the firm earned $2.17 earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. sell-side analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio is currently 33.26%.

COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Shares Bought by Jacobi Capital Management LLC” was originally posted by Stock Observer and is the sole property of of Stock Observer. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.thestockobserver.com/2017/11/15/unitedhealth-group-incorporated-unh-shares-bought-by-jacobi-capital-management-llc.html.

Several research firms have issued reports on UNH. Credit Suisse Group began coverage on UnitedHealth Group in a research report on Thursday, November 2nd. They set an “outperform” rating and a $233.00 target price on the stock. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, November 2nd. Mizuho restated a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, October 24th. Argus increased their target price on UnitedHealth Group from $215.00 to $230.00 and gave the stock a “buy” rating in a research report on Thursday, October 19th. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $219.00 target price (up previously from $210.00) on shares of UnitedHealth Group in a research report on Thursday, October 19th. Three investment analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $216.65.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply